The UK consumer healthcare industry association, PAGB, has welcomed a one-year phasing-in period for medicine-related aspects of the Northern Ireland Protocol, giving companies more time to prepare for post-Brexit regulatory changes in areas like batch testing, imports and EU Falsified Medicines Directive requirements.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?